An observational study assessing the management of gastrointestinal and urogenital bleeding events in patients with atrial fibrillation treated with dabigatran etexilate (PRADAXA)

-
Investigator: Nitish Badhwar, MD
Sponsor: Boehringer Ingleheim

Location(s): United States

Description

This study is being conducted to collect data on the management of gastrointestinal and urogenital bleeding events occurring in patients with atrial fibrillation taking dabigatran etexilate.